Latest News and Press Releases
Want to stay updated on the latest news?
-
LOUISVILLE, CO--(Marketwired - November 17, 2016) - GlobeImmune, Inc. today provided an update on the Company's business:Gilead Sciences, Inc. has terminated the collaboration and license agreement...
-
LOUISVILLE, CO--(Marketwired - July 05, 2016) - GlobeImmune, Inc. (NASDAQ: GBIM) On June 30, 2016, the board of directors (the "Board") of GlobeImmune, Inc. (the "Company") made a determination to...
-
LOUISVILLE, CO--(Marketwired - May 12, 2016) - GlobeImmune, Inc. (NASDAQ: GBIM) today provided an update on the Company's business and clinical programs and announced financial results for...
-
LOUISVILLE, CO--(Marketwired - March 16, 2016) - GlobeImmune, Inc. (NASDAQ: GBIM) today provided an update on the Company's business and clinical programs and announced financial results for...
-
LOUISVILLE, CO--(Marketwired - November 13, 2015) - GlobeImmune, Inc. (NASDAQ: GBIM), a biopharmaceutical company focused on developing products for the treatment of cancer and infectious diseases...
-
LOUISVILLE, CO--(Marketwired - August 14, 2015) - GlobeImmune, Inc. (NASDAQ: GBIM), a biopharmaceutical company focused on developing products for the treatment of cancer and infectious diseases...
-
LOUISVILLE, CO--(Marketwired - August 13, 2015) - GlobeImmune, Inc. (NASDAQ: GBIM), a biopharmaceutical company focused on developing products for the treatment of cancer and infectious diseases...
-
UPDATE - Celgene Exercises Early Option to Exclusively License GI-6207, a Novel Cancer Immunotherapy
LOUISVILLE, CO--(Marketwired - August 04, 2015) - GlobeImmune, Inc. (NASDAQ: GBIM) announced today that Celgene Corporation exercised its option under the 2009 Collaboration and Option Agreement to...
-
LOUISVILLE, CO--(Marketwired - August 04, 2015) - GlobeImmune, Inc. announced today that Celgene Corporation exercised its option under the 2009 Collaboration and Option Agreement to exclusively...
-
LOUISVILLE, CO--(Marketwired - June 10, 2015) - GlobeImmune, Inc. (NASDAQ: GBIM) today announced that it is evaluating strategic options for the company. In conjunction with this process, the Board...